Shuo Wang , Jiaheng Liang , Rui Ding , Weihao Zhao , Jianhong Zhang , Pandi Peng , Jin Chai , Yibo Yan , Peng Li
{"title":"Hierarchical ROS-scavenging platform breaks vicious cycle of stem cell senescence, angiogenesis arrest, and immune dysregulation in diabetic wounds","authors":"Shuo Wang , Jiaheng Liang , Rui Ding , Weihao Zhao , Jianhong Zhang , Pandi Peng , Jin Chai , Yibo Yan , Peng Li","doi":"10.1016/j.jconrel.2025.114247","DOIUrl":null,"url":null,"abstract":"<div><div>Diabetic chronic wounds represent a formidable clinical challenge, driven by a pathological vicious cycle of reactive oxygen species (ROS)-induced oxidative stress, stem cell senescence, angiogenesis arrest, and immune dysregulation. Herein, we developed a hierarchical ROS-scavenging platform integrating nanoscale calcium hydride (CaH₂) within a microneedle (MN) patch to disrupt this degenerative cascade. Upon dissolution in wound exudate, CaH₂ nanoparticles react with water to generate sustained release of hydrogen gas (H₂) and calcium ions (Ca<sup>2+</sup>). The liberated H₂ directly neutralizes cytotoxic ROS, thereby reversing stem cell senescence and restoring their paracrine secretion of pro-angiogenic factors, while concomitantly reprogramming macrophages toward pro-regenerative M2 phenotypes. Simultaneously, Ca<sup>2+</sup> synergizes with H₂ to activate endothelial cell migration and tubulogenesis, fostering robust vascular network formation. By concurrently resolving oxidative stress, stem cell senescence, angiogenesis arrest, and immune dysregulation, the CaH₂-MN system breaks the vicious cycle to reshape the wound microenvironment into a pro-regenerative state. In diabetic murine models, this approach accelerated wound closure, enhanced neovascularization, and reduced inflammatory infiltration. This multiscale intervention paradigm provides a blueprint for intercepting pathological cascades in diabetic wounds.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"387 ","pages":"Article 114247"},"PeriodicalIF":11.5000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365925008594","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Diabetic chronic wounds represent a formidable clinical challenge, driven by a pathological vicious cycle of reactive oxygen species (ROS)-induced oxidative stress, stem cell senescence, angiogenesis arrest, and immune dysregulation. Herein, we developed a hierarchical ROS-scavenging platform integrating nanoscale calcium hydride (CaH₂) within a microneedle (MN) patch to disrupt this degenerative cascade. Upon dissolution in wound exudate, CaH₂ nanoparticles react with water to generate sustained release of hydrogen gas (H₂) and calcium ions (Ca2+). The liberated H₂ directly neutralizes cytotoxic ROS, thereby reversing stem cell senescence and restoring their paracrine secretion of pro-angiogenic factors, while concomitantly reprogramming macrophages toward pro-regenerative M2 phenotypes. Simultaneously, Ca2+ synergizes with H₂ to activate endothelial cell migration and tubulogenesis, fostering robust vascular network formation. By concurrently resolving oxidative stress, stem cell senescence, angiogenesis arrest, and immune dysregulation, the CaH₂-MN system breaks the vicious cycle to reshape the wound microenvironment into a pro-regenerative state. In diabetic murine models, this approach accelerated wound closure, enhanced neovascularization, and reduced inflammatory infiltration. This multiscale intervention paradigm provides a blueprint for intercepting pathological cascades in diabetic wounds.
期刊介绍:
The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System.
Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.
Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.